., Nizamuddin. Effect of SGLT2 inhibitor (Empagliflozin) on HbA1c in most Prevalent Age Group of Type 2 Diabetic Patients. International Journal of Pathology, [S. l.], v. 20, n. 4, p. 178–181, 2023. Disponível em: https://jpathology.com/index.php/OJS/article/view/802.. Acesso em: 24 nov. 2024.